⌘K
t
| TIDM | ADIG |
| Share Price | Loading... |
| Market Cap | Loading... |
abrdn Diversified Income and Growth plc released its Half Yearly Report for the six months ended 30 September 2025, reporting total shareholders' funds of £151,714,000 and a Net Asset Value per Ordinary share of 50.36p, both down 25.4% year-on-year. The Company announced on 1 October 2025 that it had received binding offers or was in advanced discussions for its private markets portfolio, with sales of Fund Interests totaling approximately £10.6 million completed by 18 December 2025. Additionally, £57.2 million (19.0 pence per share) was returned to shareholders on 29 October 2025 via a B Share Scheme, and an interim dividend of 1.50 pence per share (approximately £4.5 million) was paid on 30 October 2025.
| Date | 19 Dec 2025 |
| Time | 12:00:00 |
| Category | Results |
| ID | 3195M |
abrdn Diversified Income and Growth plc
LEI - 2138003QINEGCHYGW702
Half Yearly Report for six months ended 30 September 2025
abrdndiversified.co.uk
|
|
30 September 2025 |
30 September 2024 |
% change |
|
Total shareholders' funds (Net Assets)A |
£151,714,000 |
£203,306,000 |
-25.4 |
|
Ordinary share price (mid market) |
46.00p |
44.50p |
+3.4 |
|
Net asset value per Ordinary share |
50.36p |
67.48p |
-25.4 |
|
A Decrease year-on-year reflects the write down in investment holdings' values relating to the managed wind-down process. |
|||
Managed Wind-Down update
Over the six months ended 30 September 2025, the Company's net asset value ("NAV") per share total return (including dividends) was -26.4%, an alternative performance measure, with a share price total return of -4.4%. As discussed in the previous Half-Yearly Report for the six months ended 31 March 2025 (which is available from the Company's website, https://www.aberdeeninvestments.com/en-gb/adig) the Company has appointed Campbell Lutyens & Co Ltd to market test the Company's remaining private market assets (the "Secondary Sales Process"). The Board commenced the Secondary Sales Process in order to explore opportunities to optimise the value of investments whilst seeking a progressive return of cash to shareholders in a more timely manner, in accordance with the Company's investment objective which was approved by shareholders in February 2024. I can confirm that the Company continues to make good progress with the Secondary Sales Process.
After this market testing the Board announced, on 1 October 2025, that the Company had either received binding offers for, or was in advanced discussions regarding, the entirety of its private markets' portfolio. This comprehensive process involved engaging with over 85 credible secondary market participants and resulted in more than 25 realistic non-binding offers being received (with each covering single or sub-portfolios of funds within the Company's underlying investment portfolio).
The Board, together with its advisers, assessed various overlapping proposals and negotiated the scope of the best offers seeking expedited sales to allow a timely return of capital. The pricing of the indicative offers was at a material discount to the prevailing NAV of the relevant fund interests but naturally varied by asset and asset class. The Board assessed the strategic options available to the Company on the basis of, amongst other things, the quantum expected to be delivered to shareholders (on a net present value basis), timing and relative certainty of execution. The Board notes that, in particular, the value that might be achieved for shareholders (on a net present value basis) through the implemented Secondary Sales Process was, and remains, greater than that which the Company's investment manager expected to achieve through the continuation of its original 'base case' plan for the managed wind-down which envisaged holding certain assets to maturity and selling other assets (that would otherwise mature between 2029 and 2033) in 2028. The Board also noted that by selling the portfolio's assets through the Secondary Sales Process, it accelerated significantly returns to shareholders.
During the period under review the Company redeemed, in full, its £16.7 million interest in the Aberdeen Global Private Markets Fund at its prevailing net asset value. The Company also signed binding sale and purchase agreements in respect of 13 fund investments and private market assets ("Fund Interests"), and 50% of two other Fund Interests, which together represented approximately half of the portfolio that had been marketed under the Secondary Sales Process. Such sales were agreed with funds managed by the Patria Investments group at a blended 28.5% discount to the transaction reference date valuations (before adjustment for post-reference date drawdowns and distributions). These sales were expected to raise approximately £47 million of gross consideration and included the disposal of a number of smaller secondary private equity holdings, six of which had a NAV of less than £500,000. As at the date of this document, the Company has completed three of the 15 agreed sales with two further sales expected to complete imminently. Whilst one of the proposed transfers has aborted because consent from the underlying general partner of the relevant fund was not forthcoming, the Company has received an offer for the sale of the same fund interest to another third party at the same price and the Board expects that such alternative transfer is deliverable.
As announced on 29 October 2025 and 18 December 2025, the Company has completed the sales of three other Fund Interests, raising approximately £10.6 million of gross consideration.
Portfolio valuation and basis of preparation
Following the completion of the sales described above during October and December, the Company had 15 remaining portfolio investments of which 8 were under conditional sales agreements (with 50% of a ninth investment also under a conditional sale agreement) and the remainder of which were not under binding sale agreements but were under offer (save for the Company's remaining interest in PIMCO Private Income Fund, which is expected to be realised through the redemption mechanics within the underlying fund documentation).
Following the progress made to date post period end and the expectation that most, if not all, assets held by the Company will be under a signed sale and purchase agreement or under offer in the coming weeks or months, the Board has taken the decision to prepare the Company's financial statements on a non going concern basis with assets marked down to estimates of best realisable values. The Company had, during this six month period, and for prior periods, reported daily NAV prices incorporating the previous valuation basis. As a result of this revised basis of preparation figures in these interim financial statements will therefore vary from the 30 September 2025 and 31 October 2025 NAV announcements.
As at 30 September 2025, the Company is now reporting an adjusted NAV of £151.7 million (31 March 2025 - £206.1 million), comprising the investment portfolio of £101.4 million (31 March 2025 - £171.4 million), UK treasury bills of £13.5 million and additional net current assets of £36.8 million (31 March 2025 - £34.8 million). As is more fully explained below, the Company has since returned £57.2 million pursuant to a return of capital by way of the Company's B Share Scheme and, additionally, returned £4.5 million to shareholders by way of a dividend.
Distributions to Shareholders via a B Share Scheme
The Company announced, on 29 October 2025, the return to shareholders of 19.0 pence per Ordinary Share (totalling £57.2 million) under the B Share Scheme previously approved by shareholders.
The return of capital was made by way of bonus issues, on a pro rata basis, of B Shares to all Shareholders followed by the immediate redemptions of such B Shares in consideration for a cash payment equal to the amount treated as paid up on the issues of the B Shares.
The record date for the B Shares was 13 November 2025 and the ex date was 12 November 2025. No share certificates were issued for any B Shares allotted. The B Shares were issued on 14 November 2025 and redeemed at one penny per B Share immediately after their issue; accordingly, the Redemption Date for the B Shares was 14 November 2025.
The proceeds from the redemption of the B Shares issues, equivalent to 19.0 pence per Ordinary Share, were sent to uncertificated Shareholders through CREST or to certificated Shareholders via cheque or electronic payment on 21 November 2025.
The return of capital was in addition to the Company's interim dividend of 1.50 pence per Ordinary Share which was paid to shareholders on 30 October 2025, as discussed below.
The apportionment ratio between the B Shares and the Ordinary Shares, for UK capital gains tax purposes, has been published in the Literature section of the Company's website (https://www.aberdeeninvestments.com/en-gb/adig/literature) within the subsection titled "Key documents".
Future returns of capital and potential timeline for the managed wind-down
The Board intends to make a further return of capital in the first quarter of 2026 either by way of the B Share Scheme or as an initial distribution under a members' voluntary liquidation.
In the light of the progress made by the Company in realising its investments, the Board is exploring putting forward proposals in the first quarter of 2026 to place the Company into a solvent members' voluntary liquidation if substantially all of the Company's investments have been realised by such time. It is likely that certain of the Company's assets (such as PIMCO Private Income Fund, which is expected to be exited through the fund's redemption mechanics in the fourth quarter of 2026, and any private market assets that are not sold in the Secondary Sales Process by the commencement of the liquidation) would be retained by the liquidators and realised during the liquidation period thereafter.
The remaining proceeds from the realisation of the Company's portfolio prior to and during the liquidation period would be distributed to shareholders after the Company's outstanding liabilities and the costs of implementing the proposals, including the liquidators' fees, have been met.
Thanks to the progress with the Secondary Sales Process, the Board remains on track to put forward proposals in the first quarter of 2026 to place the Company into members' voluntary liquidation. With that said, there can be no certainty as to the precise quantum or timing for the completion of any further realisations or returns of capital arising out of or in connection with the Secondary Sales Process.
Dividend
The Board of the Company announced, on 25 September 2025, an interim dividend of 1.50 pence per share on the Ordinary Shares of the Company, being approximately £4.5 million in aggregate. The interim dividend was paid on 30 October 2025 to shareholders on the register on 3 October 2025. The ex-dividend date was 2 October 2025.
As indicated previously, the Board intends to pay only a sufficient level of dividend to ensure that the Company will not retain more than 15 per cent. of its income in an accounting period in order to maintain the Company's investment trust status during its managed wind-down.
Shareholders should be aware that the Company's capacity for revenue generation substantially decreased following the sale of the public markets assets and will reduce further as the private markets' assets are realised under the Secondary Sales Process and capital is returned to shareholders.
Change to accounting reference date
In the light of the potential timeline for liquidation mentioned above, the Board resolved to change the Company's accounting reference date for the previous accounting period from the year ended to 30 September 2025 to the 18 months ended 31 March 2026. This change avoids unnecessary work being undertaken before the Company enters into liquidation (if it does so in the first quarter of 2026) by deferring the requirement to publish an annual report and audited financial statements. This change is expected to result in a cost saving for the Company and, accordingly, is considered to be in the best interests of shareholders.
As a result of this change, the Company's reporting timetable is as follows (in each case unless the Company has entered into members' voluntary liquidation prior to the relevant deadline for publication), noting that this report constitutes a further interim report, for the six months ended 30 September 2025, after publication in June 2025 of an interim report for the six months ended 31 March 2025:
- publication of an annual report and audited financial statements for the financial year ending 31 March 2026, by no later than 31 July 2026.
- from then, interim and annual reports would be published each year for the six months to 30 September and the 12 months to 31 March, respectively.
Davina Walter
Chairman
19 December 2025
The Chairman's Statement provides details of the important events which have occurred during the period and their impact on the financial statements.
The principal risks faced by the Company can be divided into various areas as follows:
· Performance risk;
· Regulatory risk;
· Operational risk;
· Market risk; and
· Financial risks.
The Board reported on the principal risks and uncertainties faced by the Company in the Annual Report and Financial Statements for the year ended 30 September 2024 (the "Annual Report"); a detailed explanation can be found in the Strategic Report on pages 9 and 10 of the Annual Report which is available on the Company's website: abrdndiversified.co.uk
The Board is monitoring the heightened geopolitical risks in the form of the Russian invasion of Ukraine, the conflict in the Middle East and recent and rising tension between China and Taiwan.
The Board is also conscious of the elevated threat posed by climate change and continues to monitor, through its Investment Manager, the potential risk that its portfolio investments may fail to adapt to the requirements imposed by climate change.
In the view of the Board, there have not been any other changes to the fundamental nature of the principal risks and uncertainties facing the Company since the previous Annual Report, which are considered to be equally applicable to the remaining six months of the 18 months ended 31 March 2026.
The Financial Statements have been prepared on a basis other than the going concern basis as noted in the Chairman's Statement and as more fully set out in Note 1 to the Financial Statements. In particular, investment valuations have been adjusted to reflect achieved or anticipated disposal values on or subsequent to 30 September 2025 and provisions made for the anticipated costs for completion of the Secondary Sales Process and ultimate liquidation of the Company.
The Company is able to meet all of its liabilities from its remaining assets, including its ongoing operating expenses.
abrdn Fund Managers Limited ("AFML") has been appointed as the Company's alternative investment fund manager.
AFML has (with the Company's consent) delegated certain portfolio and risk management services, and other ancillary services, to abrdn Investments Limited and abrdn Holdings Limited, which are regarded as related parties under the UK Listing Rules issued by the Financial Conduct Authority ("FCA"). Details of the fees payable to AFML are set out in note 3 to the condensed financial statements.
The Disclosure Guidance and Transparency Rules of the UK Listing Authority require the Directors to confirm their responsibilities in relation to the preparation and publication of the Interim Management Report and Financial Statements.
The Directors confirm to the best of their knowledge that:
· the condensed set of financial statements contained within the Half Yearly Financial Report has been prepared in accordance with applicable UK Accounting Standard FRS 104 'Interim Financial Reporting' and give a true and fair view of the assets, liabilities, financial position and return of the Company for the six months ended 30 September 2025; and
· the Interim Management Report, together with the Chairman's Statement, includes a fair review of the information required by 4.2.7R and 4.2.8R of the FCA's Disclosure Guidance and Transparency Rules.
The Half-Yearly Financial Report was approved by the Board and the above Directors' Responsibility Statement was signed on its behalf by the Chairman.
For and on behalf of the Board
Davina Walter
Chairman
19 December 2025
|
|
At |
At |
|
|
30 September |
30 September |
|
|
2025 |
2024 |
|
|
% of Total |
% of Total |
|
|
investments |
investments |
|
SL Capital Infrastructure IIAB |
15.6 |
15.2 |
|
European economic infrastructure |
|
|
|
Bonaccord Capital Partners I-AB |
11.8 |
10.0 |
|
Investments in alternative asset management companies |
|
|
|
UK(Govt Of) 0% 27/10/25 GBP |
11.7 |
- |
|
UK gilt |
|
|
|
Andean Social Infrastructure Fund IAB |
11.5 |
8.7 |
|
Infrastructure project investments in the Andean region of South America |
|
|
|
Patria Secondaries Opportunities Fund IVB |
11.3 |
8.8 |
|
Diversified Private Equity portfolio which invests through secondary transactions |
|
|
|
Burford Opportunity FundB |
9.0 |
8.9 |
|
Litigation finance investments initiated by Burford Capital |
|
|
|
Healthcare Royalty Partners IVB |
7.3 |
6.8 |
|
Healthcare royalty streams primarily in the US |
|
|
|
TrueNoord Co-InvestmentB |
5.3 |
3.9 |
|
Aircraft leasing company which specialised in regional aircraft |
|
|
|
ASI Hark IIIB |
3.1 |
2.2 |
|
Lends capital on a NAV-financing basis to private equity backed companies or investment vehicles |
|
|
|
Aberdeen Property Secondaries Partners IIAB |
3.0 |
4.3 |
|
Real estate portfolio of properties across United Kingdom and Europe |
|
|
|
A Denotes Aberdeen Group plc managed products. |
|
|
|
B Unlisted holdings. |
|
|
|
As at 30 September 2025 |
|||
|
|
Valuation |
Valuation |
Valuation |
|
|
30 September 2025 |
30 September 2025 |
30 September 2024 |
|
Company |
£'000 |
% |
£'000 |
|
Private Equity |
|
|
|
|
Bonaccord Capital Partners I-A |
13,581 |
11.8 |
18,130 |
|
Patria Secondaries Opportunities Fund IVB |
12,991 |
11.3 |
16,057 |
|
TrueNoord Co-InvestmentB |
6,066 |
5.3 |
7,136 |
|
Maj Invest Equity VC |
1,410 |
1.2 |
2,095 |
|
HarbourVest International Private Equity VIC |
388 |
0.4 |
1,240 |
|
Mesirow Financial Private Equity IVC |
151 |
0.1 |
400 |
|
HarbourVest VIII Venture FundC |
45 |
0.1 |
104 |
|
Maj Invest Equity IVC |
12 |
- |
24 |
|
Dover Street VIIC |
2 |
- |
4 |
|
HarbourVest VIII Buyout FundC |
1 |
- |
23 |
|
Total Private Equity |
34,647 |
30.2 |
|
|
Real Estate |
|
|
|
|
Aberdeen Property Secondaries Partners IIAC |
3,515 |
3.0 |
7,840 |
|
Cheyne Social Property Impact FundD |
1,909 |
1.7 |
3,299 |
|
Aberdeen European Residential Opportunities Fund A |
- |
- |
2,556 |
|
Total Real Estate |
5,424 |
4.7 |
|
|
Infrastructure |
|
|
|
|
SL Capital Infrastructure IIA |
17,947 |
15.6 |
27,792 |
|
Andean Social Infrastructure Fund IAC |
13,249 |
11.5 |
15,821 |
|
BlackRock Renewable Income - UK |
3,100 |
2.7 |
6,657 |
|
Aberdeen Global Infrastructure Partners II (AUD)AC |
1,919 |
1.7 |
2,250 |
|
Pan European Infrastructure FundD |
233 |
0.2 |
768 |
|
Total Infrastructure |
36,448 |
31.7 |
|
|
A Denotes Aberdeen Group plc managed products. |
|
|
|
|
B Sold under conditional SPAs with Patria Investments Group - completed October 2025. |
|||
|
C Sold under conditional SPAs with Patria Investment Group - completing post October 2025. 50% of Andean Social Infrastructure under those SPAs. |
|||
|
D Sold after the period end under conditional SPAs. |
|
|
|
|
Private Credit |
|
|
|
|
ASI Hark IIIB |
3,528 |
3.1 |
4,109 |
|
PIMCO Private Income Fund Offshore Feeder I LP |
2,362 |
2.0 |
6,736 |
|
Mount Row Credit Fund IIE |
309 |
0.3 |
9,393 |
|
Total Private Credit |
6,199 |
5.4 |
|
|
Other |
|
|
|
|
Burford Opportunity Fund |
10,262 |
9.0 |
16,120 |
|
Healthcare Royalty Partners IVD |
8,418 |
7.3 |
12,263 |
|
Total Other |
18,680 |
16.3 |
|
|
Total Private Markets |
101,398 |
88.3 |
|
|
B Sold under conditional SPAs with Patria Investments Group - completed October 2025. 50% of ASI Hark III under those SPAs. |
|||
|
D Sold after the period end under conditional SPAs. |
|||
|
E Redeemed after the period end. |
|||
|
As at 30 September 2025 |
|||
|
|
Valuation |
Valuation |
Valuation |
|
|
30 September 2025 |
30 September 2025 |
30 September 2024 |
|
Investment |
£'000 |
% |
£'000 |
|
Developed Market Government Treasury Bills |
|
|
|
|
UK(Govt Of) 0% 27/10/25 GBP |
13,459 |
11.7 |
- |
|
Total Developed Market Government Bonds |
13,459 |
11.7 |
|
|
Total Fixed Income & Credit |
13,459 |
11.7 |
|
|
As at 30 September 2025 |
||||
|
|
Valuation |
Net assets |
Valuation |
Net assets |
|
|
30 September 2025 |
30 September 2025 |
30 September 2024 |
30 September 2024 |
|
|
£'000 |
% |
£'000 |
% |
|
Total investments |
114,857 |
75.7 |
182,525 |
89.8 |
|
Cash and cash equivalents |
41,342 |
27.3 |
22,300 |
11.0 |
|
Other net liabilities |
(4,485) |
(3.0) |
(1,519) |
(0.8) |
|
Net assets |
151,714 |
100.0 |
203,306 |
100.0 |
|
|
|
Six months ended |
Twelve months ended |
||||
|
|
|
30 September 2025 |
30 September 2025 |
||||
|
|
|
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
|
|
Notes |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
Losses on investments |
|
- |
(50,535) |
(50,535) |
- |
(43,748) |
(43,748) |
|
Foreign exchange gains |
|
- |
(104) |
(104) |
- |
92 |
92 |
|
Income |
2 |
2,224 |
- |
2,224 |
4,883 |
- |
4,883 |
|
Investment management fees |
3 |
(26) |
(231) |
(257) |
(53) |
(474) |
(527) |
|
Administrative expenses |
|
(1,096) |
(4,204) |
(5,300) |
(1,451) |
(4,245) |
(5,696) |
|
Net return before finance costs and taxation |
|
1,102 |
(55,074) |
(53,972) |
3,379 |
(48,375) |
(44,996) |
|
|
|
|
|
|
|
|
|
|
Finance costs |
|
(1) |
(13) |
(14) |
(1) |
(14) |
(15) |
|
Net return before taxation |
|
1,101 |
(55,087) |
(53,986) |
3,378 |
(48,389) |
(45,011) |
|
|
|
|
|
|
|
|
|
|
Taxation |
4 |
(438) |
- |
(438) |
(706) |
- |
(706) |
|
Return attributable to equity shareholders |
|
663 |
(55,087) |
(54,424) |
2,672 |
(48,389) |
(45,717) |
|
|
|
|
|
|
|
|
|
|
Return per Ordinary share (pence) |
5 |
0.22 |
(18.29) |
(18.07) |
0.89 |
(16.06) |
(15.17) |
|
|
|
|
|
|
|
|
|
|
The total column of the Condensed Statement of Comprehensive Income is the profit and loss account of the Company. There has been no other comprehensive income during the period, accordingly, the return attributable to equity shareholders is equivalent to the total comprehensive income/(loss) for the period. |
|||||||
|
All revenue and capital items in the above statement derive from previously continuing operations. As these financial statements have been prepared on a non-going concern basis, as described in note 1, all operations are now deemed to be discontinued. |
|||||||
|
The accompanying notes are an integral part of these condensed financial statements. |
|||||||
|
|
|
Six months ended |
Twelve months ended |
||||
|
|
|
30 September 2024 |
30 September 2024 |
||||
|
|
|
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
|
|
Notes |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
Losses on investments |
|
- |
(8,928) |
(8,928) |
- |
(16,112) |
(16,112) |
|
Foreign exchange gains |
|
- |
(119) |
(119) |
- |
5,601 |
5,601 |
|
Income |
2 |
8,239 |
- |
8,239 |
15,638 |
- |
15,638 |
|
Investment management fees |
3 |
(207) |
(207) |
(414) |
(474) |
(474) |
(948) |
|
Administrative expenses |
|
(434) |
(344) |
(778) |
(1,006) |
(503) |
(1,509) |
|
Net return before finance costs and taxation |
|
7,598 |
(9,598) |
(2,000) |
14,158 |
(11,488) |
2,670 |
|
|
|
|
|
|
|
|
|
|
Finance costs |
|
(22) |
(22) |
(44) |
(284) |
(3,043) |
(3,327) |
|
Net return before taxation |
|
7,576 |
(9,620) |
(2,044) |
13,874 |
(14,531) |
(657) |
|
|
|
|
|
|
|
|
|
|
Taxation |
4 |
(1,864) |
- |
(1,864) |
(2,961) |
(37) |
(2,998) |
|
Return attributable to equity shareholders |
|
5,712 |
(9,620) |
(3,908) |
10,913 |
(14,568) |
(3,655) |
|
|
|
|
|
|
|
|
|
|
Return per Ordinary share (pence) |
5 |
1.90 |
(3.20) |
(1.30) |
3.62 |
(4.83) |
(1.21) |
|
|
|
|
|
|
|
|
|
|
The total column of the Condensed Statement of Comprehensive Income is the profit and loss account of the Company. There has been no other comprehensive income during the period, accordingly, the return attributable to equity shareholders is equivalent to the total comprehensive income/(loss) for the period. |
|||||||
|
All revenue and capital items in the above statement derive from previously continuing operations. As these financial statements have been prepared on a non-going concern basis, as described in note 1, all operations are now deemed to be discontinued. |
|||||||
|
The accompanying notes are an integral part of these condensed financial statements. |
|||||||
|
|
|
As at |
As at |
|
|
|
30 September 2025 |
30 September 2024 |
|
|
|
(unaudited) |
(audited) |
|
|
Notes |
£'000 |
£'000 |
|
Non-current assets |
|
|
|
|
Investments at fair value through profit or loss |
|
- |
182,525 |
|
|
|
- |
182,525 |
|
|
|
|
|
|
Current assets |
|
|
|
|
Investments at realisable value through profit or loss |
12 |
114,857 |
- |
|
Other debtors and receivables |
|
434 |
633 |
|
Cash and cash equivalents |
|
41,342 |
22,300 |
|
|
|
156,633 |
22,933 |
|
|
|
|
|
|
Creditors: amounts falling due within one year |
|
|
|
|
Other payables |
|
(4,919) |
(2,152) |
|
|
|
(4,919) |
(2,152) |
|
Net current assets |
|
151,714 |
20,781 |
|
Total assets less current liabilities |
|
151,714 |
203,306 |
|
Net assets |
|
151,714 |
203,306 |
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
Called up share capital |
9 |
3,238 |
3,238 |
|
Capital redemption reserve |
|
- |
114,768 |
|
Special distributable reserve |
|
116,531 |
1,763 |
|
Capital reserve |
|
6,760 |
55,149 |
|
Revenue reserve |
|
25,185 |
28,388 |
|
Total shareholders' funds |
|
151,714 |
203,306 |
|
|
|
|
|
|
Net asset value per Ordinary share (pence) |
10 |
50.36 |
67.48 |
|
|
|
|
|
|
The accompanying notes are an integral part of these condensed financial statements. |
|||
|
Twelve months ended 30 September 2025 |
|||||||||
|
|
|
Ordinary |
|
Share |
Capital |
Special |
|
|
|
|
|
|
share |
B share |
premium |
redemption |
distributable |
Capital |
Revenue |
|
|
|
|
capital |
capital |
account |
reserve |
reserve |
reserve |
reserve |
Total |
|
|
Notes |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
At 1 October 2024 |
|
3,238 |
- |
- |
114,768 |
1,763 |
55,149 |
28,388 |
203,306 |
|
Return after taxation |
|
- |
- |
- |
- |
- |
(48,389) |
2,672 |
(45,717) |
|
Cancellation of Capital Redemption Reserve |
|
- |
- |
- |
(114,768) |
114,768 |
- |
- |
- |
|
Dividends paid |
6 |
- |
- |
- |
- |
- |
- |
(5,875) |
(5,875) |
|
At 30 September 2025 |
|
3,238 |
- |
- |
- |
116,531 |
6,760 |
25,185 |
151,714 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Twelve months ended 30 September 2024 |
|||||||||
|
|
|
Ordinary |
|
Share |
Capital |
Special |
|
|
|
|
|
|
share |
B share |
premium |
redemption |
distributable |
Capital |
Revenue |
|
|
|
|
capital |
capital |
account |
reserve |
reserve |
reserve |
reserve |
Total |
|
|
Notes |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
At 1 October 2023 |
|
80,938 |
- |
116,556 |
37,043 |
- |
69,717 |
35,280 |
339,534 |
|
Return after taxation |
|
- |
- |
- |
- |
- |
(14,568) |
10,913 |
(3,655) |
|
B shares issued during the year |
|
- |
114,768 |
- |
- |
- |
- |
- |
114,768 |
|
B shares redeemed during the year |
|
- |
(114,768) |
- |
114,768 |
(114,768) |
- |
- |
(114,768) |
|
Return of capital to B shareholders |
|
- |
- |
- |
- |
(114,768) |
- |
- |
(114,768) |
|
Cancellation and reduction of Ordinary shares |
|
(77,700) |
- |
(116,556) |
(37,043) |
231,299 |
- |
- |
- |
|
Dividends paid |
6 |
- |
- |
- |
- |
- |
- |
(17,805) |
(17,805) |
|
At 30 September 2024 |
|
3,238 |
- |
- |
114,768 |
1,763 |
55,149 |
28,388 |
203,306 |
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these condensed financial statements. |
|||||||||
|
|
|
Twelve months ended |
Twelve months ended |
|
|
|
30 September 2025 |
30 September 2024 |
|
|
Note |
£'000 |
£'000 |
|
Operating activities |
|
|
|
|
Net return before finance costs and taxation |
|
(44,996) |
2,670 |
|
Adjustments for: |
|
|
|
|
Dividend income |
|
- |
(3,306) |
|
Distribution income |
|
(3,763) |
(8,935) |
|
Fixed interest income |
|
- |
(1,074) |
|
Treasury bill income |
|
- |
(1,140) |
|
Interest income |
|
(1,117) |
(1,177) |
|
Other income |
|
(3) |
(6) |
|
Dividends received |
|
- |
3,434 |
|
Distributions received |
|
3,763 |
8,914 |
|
Fixed interest income received |
|
- |
1,652 |
|
Treasury bill income received |
|
|
1,140 |
|
Interest received |
|
1,082 |
1,145 |
|
Other income received |
|
3 |
6 |
|
Gains on forward contracts |
|
- |
(5,615) |
|
Foreign exchange losses |
|
87 |
154 |
|
Losses on investments |
|
43,748 |
16,166 |
|
Decrease/(increase) in other debtors |
|
52 |
(7) |
|
Increase/(decrease) in accruals |
|
4,567 |
(482) |
|
Corporation tax paid |
|
(2,571) |
(1,923) |
|
Taxation released |
|
247 |
120 |
|
Net cash flow from operating activities |
|
1,099 |
11,736 |
|
|
|
|
|
|
Investing activities |
|
|
|
|
Purchases of investments and capital calls |
|
(12,777) |
(190,990) |
|
Realised gains on investee distributions |
|
26,630 |
8,181 |
|
Sales of investments and return of capital |
|
10,067 |
324,187 |
|
Net cash flow from investing activities |
|
23,920 |
141,378 |
|
|
|
|
|
|
Financing activities |
|
|
|
|
Redemption of B shares |
|
- |
(114,768) |
|
Redemption of 6.25% Bond |
|
- |
(18,508) |
|
Interest paid |
|
(15) |
(604) |
|
Equity dividends paid |
6 |
(5,875) |
(17,805) |
|
Net cash flow used in financing activities |
|
(5,890) |
(151,685) |
|
Increase in cash and cash equivalents |
|
19,129 |
1,429 |
|
|
|
|
|
|
Analysis of changes in cash and cash equivalents during the period |
|
|
|
|
Opening balance |
|
22,300 |
21,025 |
|
Foreign exchange |
|
(87) |
(154) |
|
Increase in cash and cash equivalents as above |
|
19,129 |
1,429 |
|
Closing balance |
|
41,342 |
22,300 |
|
|
|
|
|
|
Represented by: |
|
|
|
|
Money market funds |
|
39,300 |
20,516 |
|
Cash at bank and in hand |
|
2,042 |
1,784 |
|
Closing balance |
|
41,342 |
22,300 |
|
|
|
|
|
|
The accompanying notes are an integral part of these condensed financial statements. |
|||
For the six months 30 September 2025
|
1. |
Accounting policies - Basis of accounting |
|
|
The condensed financial statements have been prepared in accordance with Financial Reporting Standard 104 (Interim Financial Reporting) and with the Statement of Recommended Practice for 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued in July 2022 and with the Disclosure Guidance Transparency Rules issued by the Financial Conduct Authority. |
|
|
Following an extensive review of the Company's strategy and discussions with major shareholders, resolutions were put to and approved by Shareholders at the Annual General Meeting of the Company held on 27 February 2024 adopting the new investment objective and policy, approving a managed wind-down of the Company. |
|
|
The Company's further announcement which was made on 16 April 2025 confirmed that the Board had appointed Campbell Lutyens as an independent broker to market-test demand for the Company's private markets assets and to undertake a secondary sales process with the aim of optimising the value of the Company's investments whilst progressively returning cash to Shareholders. |
|
|
An update on the Secondary Sales Process provided by the Company on 1 October 2025 notified Shareholders of a material disposal of a number of assets. Since then, further progress has been made regarding the disposal of the remaining assets. As a consequence, the Board determined that the going concern basis of preparation of the financial statements for the six months ended 30 September 2025 is no longer appropriate given that the likely outcome of the current process will ultimately lead to the proposed liquidation of the Company following further expected sales and returns of capital deemed likely to take place within twelve months of the date of this report. Events subsequent to the balance sheet date have been taken into account in preparing these financial statements, in particular adjustments to the valuation of the Company's investments to reflect realisable value, and account provisions for the completion of the Secondary Sales Process and ultimate liquidation of the Company. |
|
|
The reporting of daily net asset values ("NAVs") during the period was consistent with the previously published basis of investment valuation. From 1 October 2025, the Company reverted to reporting NAVs on a monthly basis, applying the amended basis of investment valuation. |
|
|
Subject to an amended basis for investment valuation and liquidation provisions as noted above the interim financial statements have been prepared using the same accounting policies as the preceding annual financial statements. Investments at 30 September 2025 are held at realisable value and classified as current assets as they are expected to be sold within twelve months of the date of this report. There have been no new standards, amendments or interpretations, specific to the Company, effective for the first time for this interim period that require a change in accounting policies. |
|
|
Significant accounting judgements, estimates and assumptions. The preparation of financial statements requires the use of certain significant accounting judgements, estimates and assumptions which requires Directors to exercise their judgement in the process of applying the accounting policies. In accordance with the expectation of the portfolio of investments being sold within twelve months of the date of this report, and the Company being placed into members' voluntary liquidation, the financial statements have been prepared under a basis other than going concern. |
|
2. |
Income |
|
|
|
|
|
|
|
Six months ended |
Twelve months ended |
Six months ended |
Twelve months ended |
|
|
|
30 September 2025 |
30 September 2025 |
30 September 2024 |
30 September 2024 |
|
|
|
£'000 |
£'000 |
£'000 |
£'000 |
|
|
Income from investments |
|
|
|
|
|
|
UK listed dividends |
- |
- |
(38) |
436 |
|
|
Overseas listed dividends |
- |
- |
475 |
2,870 |
|
|
Unquoted Limited Partnership income |
1,584 |
3,763 |
5,843 |
8,935 |
|
|
Treasury bill income |
- |
- |
1,002 |
1,140 |
|
|
Fixed interest income |
- |
- |
39 |
1,074 |
|
|
|
1,584 |
3,763 |
7,321 |
14,455 |
|
|
|
|
|
|
|
|
|
Other income |
|
|
|
|
|
|
Deposit interest |
5 |
9 |
37 |
108 |
|
|
Interest from money market funds |
635 |
1,108 |
881 |
1,069 |
|
|
Other income |
- |
3 |
- |
6 |
|
|
|
640 |
1,120 |
918 |
1,183 |
|
|
Total income |
2,224 |
4,883 |
8,239 |
15,638 |
|
3. |
Investment management fees |
||||||||||||
|
|
|
Six months ended |
Twelve months ended |
Six months ended |
Twelve months ended |
||||||||
|
|
|
30 September 2025 |
30 September 2025 |
30 September 2024 |
30 September 2024 |
||||||||
|
|
|
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
|
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
|
Investment management fee |
26 |
231 |
257 |
53 |
474 |
527 |
207 |
207 |
414 |
474 |
474 |
948 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The investment management fee has been levied by abrdn Fund Managers Limited ("AFML") at the following tiered levels: |
||||||||||||
|
|
- 0.50% per annum in respect of the first £300 million of the net asset value (with the 6.25% Bonds 2031 at fair value in the prior year); and |
||||||||||||
|
|
- 0.45% per annum in respect of the balance of the net asset value (with the 6.25% Bonds 2031 at fair value in the prior year). |
||||||||||||
|
|
With effect from 1 October 2024, management fees are allocated 90% to capital and 10% to revenue, reflecting the anticipated split of investment returns during the Managed Wind-Down of the Company (previously allocated 50% capital and 50% revenue). |
||||||||||||
|
|
The Company also receives rebates in respect of underlying investments in other funds managed by Aberdeen (the Group) (where an investment management fee is charged by the Group on that fund) in the normal course of business to ensure that no double counting occurs. Any investments made in funds managed by the Manager which themselves invest directly into alternative investments including, but not limited to, infrastructure and property are charged at the Manager's lowest institutional fee rate. To avoid double charging, such investments are excluded from the overall management fee calculation. For further information see note 13 to the condensed financial statements. |
||||||||||||
|
|
At the period end, an amount of £78,000 (30 September 2024 - £90,000) was outstanding in respect of management fees due by the Company. |
||||||||||||
|
4. |
Taxation |
|
|
The taxation charge for the period represents withholding tax refunded and corporation tax paid. |
|
|
The Company has not recognised a deferred tax asset (30 September 2024 - £nil) as it is considered unlikely that sufficient taxable profits will be generated in the future to utilise these amounts and therefore no deferred tax asset has been recognised. |
|
|
The Company does not apply the marginal method of allocation of tax relief. |
|
5. |
Return per Ordinary share |
||||
|
|
|
Six months ended |
Twelve months ended |
Six months ended |
Twelve months ended |
|
|
|
30 September 2025 |
30 September 2025 |
30 September 2024 |
30 September 2024 |
|
|
|
p |
p |
p |
p |
|
|
Revenue return |
0.22 |
0.89 |
1.90 |
3.62 |
|
|
Capital return |
(18.29) |
(16.06) |
(3.20) |
(4.83) |
|
|
Total return |
(18.07) |
(15.17) |
(1.30) |
(1.21) |
|
|
|
|
|
|
|
|
|
The figures above are based on the following: |
||||
|
|
|
|
|
|
|
|
|
|
Six months ended |
Twelve months ended |
Six months ended |
Twelve months ended |
|
|
|
30 September 2025 |
30 September 2025 |
30 September 2024 |
30 September 2024 |
|
|
|
£'000 |
£'000 |
£'000 |
£'000 |
|
|
Revenue return |
663 |
2,672 |
5,712 |
10,913 |
|
|
Capital return |
(55,087) |
(48,389) |
(9,620) |
(14,568) |
|
|
Total return |
(54,424) |
(45,717) |
(3,908) |
(3,655) |
|
|
|
|
|
|
|
|
|
Weighted average number of shares in issueA |
301,265,952 |
301,265,952 |
301,265,952 |
301,265,952 |
|
|
A Calculated excluding shares held in treasury. |
|
|
|
|
|
6. |
Dividends |
|
|
|
|
|
Twelve months ended |
Twelve months ended |
|
|
|
30 September 2025 |
30 September 2024 |
|
|
|
£'000 |
£'000 |
|
|
Second interim dividend for 2024 - 1.95p |
5,875 |
- |
|
|
Third interim dividend for 2024 - nil (2023 - 1.42p) |
- |
4,278 |
|
|
Special dividend for 2024 - nil (2023 - 1.65p) |
- |
4,971 |
|
|
Fourth interim dividend for 2024 - nil (2023 - 1.42p) |
- |
4,278 |
|
|
First interim dividend for 2025 - nil (2024 - 1.42p) |
- |
4,278 |
|
|
|
5,875 |
17,805 |
|
|
|
|
|
|
|
On 25 September 2025, the Board declared an interim dividend of 1.50 pence per share which was paid on 30 October 2025 to shareholders on the register on 2 October 2025. |
||
|
|
From the adoption of the Managed Wind-Down investment policy, dividends will be paid only to ensure that the Company continues to maintain its investment trust status. |
||
|
7. |
6.25% Bonds 2031 |
|
|
|
|
|
Twelve months ended |
Twelve months ended |
|
|
|
30 September 2025 |
30 September 2024 |
|
|
|
£'000 |
£'000 |
|
|
Balance at beginning of period |
- |
15,730 |
|
|
Amortisation of discount and issue expenses |
- |
19 |
|
|
Loss on early repayment |
- |
2,759 |
|
|
Repayment |
- |
(18,508) |
|
|
Balance at end of period |
- |
- |
|
|
|
|
|
|
|
On 9 April 2024, the 6.25% Bonds were repaid early at a price of 114.983%, resulting in a total cost of £18,587,000, including accrued interest of £79,000 thereon. |
||
|
8. |
Analysis of changes in net cash/(debt) |
||||
|
|
|
At |
|
Non-cash |
At |
|
|
|
1 October 2024 |
Cash flows |
movements |
30 September 2025 |
|
|
|
£000 |
£000 |
£000 |
£000 |
|
|
Cash and cash equivalents |
22,300 |
19,042 |
- |
41,342 |
|
|
Total |
22,300 |
19,042 |
- |
41,342 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At |
|
Non-cash |
At |
|
|
|
1 October 2023 |
Cash flows |
movements |
30 September 2024 |
|
|
|
£000 |
£000 |
£000 |
£000 |
|
|
Cash and cash equivalents |
21,025 |
1,275 |
- |
22,300 |
|
|
Debt due after one year |
(15,730) |
18,508 |
(2,778) |
- |
|
|
Total |
5,295 |
19,783 |
(2,778) |
22,300 |
|
|
|
|
|
|
|
|
|
Cash equivalents are held in a money market fund. |
||||
|
9. |
Called up share capital |
|
|
At the end of the period there were 301,265,952 (30 September 2024 - 301,265,952) Ordinary shares in issue and 22,485,854 (30 September 2024 - 22,485,854) shares held in treasury. During the period no Ordinary shares of 25p each were purchased (year ended 30 September 2024 - nil). |
|
10. |
Net asset value per Ordinary share |
|
|
|
||||
|
|
|
As at |
As at |
|
||||
|
|
|
30 September 2025 |
30 September 2024 |
|
||||
|
|
Debt at par |
|
|
|
||||
|
|
Net asset value attributable (£'000) |
151,714 |
203,306 |
|
||||
|
|
Number of Ordinary shares in issue excluding treasury |
301,265,952 |
301,265,952 |
|
||||
|
|
Net asset value per share (p) |
50.36 |
67.48 |
|
||||
|
11. |
Transaction costs |
|
|
|
|
|||
|
|
During the period expenses were incurred in acquiring or disposing of investments classified as fair value through profit or loss. These have been expensed through capital and are included within losses on investments in the Condensed Statement of Comprehensive Income. The total costs were as follows: |
|||||||
|
|
|
|
|
|
|
|||
|
|
|
Six months ended |
Twelve months ended |
Six months ended |
Twelve months ended |
|||
|
|
|
30 September 2025 |
30 September 2025 |
30 September 2024 |
30 September 2024 |
|||
|
|
|
£'000 |
£'000 |
£'000 |
£'000 |
|||
|
|
Purchases |
- |
- |
- |
6 |
|||
|
|
Sales |
- |
- |
3 |
69 |
|||
|
|
|
- |
- |
3 |
75 |
|||
|
12. |
Fair value hierarchy |
|
|
|
|
||||
|
|
FRS 102 requires an entity to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels: |
||||||||
|
|
Level 1 - Quoted prices in active markets for identical instruments. A financial instrument is regarded as quoted in an active market if quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service or regulatory agency, and those prices represent actual and regularly occurring market transactions on an arm's length basis. The Company does not adjust the quoted price for these instruments. |
||||||||
|
|
Level 2 - Valuation techniques using observable inputs. This category includes instruments valued using quoted prices for similar instruments in markets that are considered less than active; or other valuation techniques where all significant inputs are directly or indirectly observable from market data. |
||||||||
|
|
Valuation techniques used for non-standardised financial instruments such as over-the-counter derivatives, include the use of comparable recent arm's length transactions, reference to other instruments that are substantially the same, discounted cash flow analysis, option pricing models and other valuation techniques commonly used by market participants making the maximum use of market inputs and relying as little as possible on entity specific inputs. |
||||||||
|
|
Level 3 - Valuation techniques using significant unobservable inputs. This category includes all instruments where the valuation technique includes inputs not based on observable data and the unobservable inputs could have a significant impact on the instrument's valuation. |
||||||||
|
|
This category also includes instruments that are valued based on quoted prices for similar instruments where significant entity determined adjustments or assumptions are required to reflect differences between the instruments and instruments for which there is no active market. The investment manager considers observable data to be that market data that is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant market. |
||||||||
|
|
The level in the fair value hierarchy within which the fair value measurement is categorised in its entirety is determined on the basis of the lowest level input that is significant to the fair value measurement. For this purpose, the significance of an input is assessed against the fair value measurement in its entirety. If a fair value measurement uses observable inputs that require significant adjustment based on unobservable inputs, that measurement is a Level 3 measurement. |
||||||||
|
|
Assessing the significance of a particular input to the fair value measurement in its entirety requires judgement, considering factors specific to the asset or liability. |
||||||||
|
|
The financial assets and liabilities measured at fair value in the Condensed Statement of Financial Position are grouped into the fair value hierarchy at the reporting date as follows: |
||||||||
|
|
|
|
|
|
|
||||
|
|
|
Level 1 |
Level 2 |
Level 3 |
Total |
||||
|
|
As at 30 September 2025 |
£'000 |
£'000 |
£'000 |
£'000 |
||||
|
|
Financial assets at realisable value through profit or loss |
|
|
|
|
||||
|
|
Equity investments |
- |
- |
101,398 |
101,398 |
||||
|
|
Fixed interest instruments |
13,459 |
- |
- |
13,459 |
||||
|
|
Net fair value |
13,459 |
- |
101,398 |
114,857 |
||||
|
|
|
|
|
|
|
||||
|
|
|
Level 1 |
Level 2 |
Level 3 |
Total |
||||
|
|
As at 30 September 2024 |
£'000 |
£'000 |
£'000 |
£'000 |
||||
|
|
Financial assets at fair value through profit or loss |
|
|
|
|
||||
|
|
Equity investments |
79 |
- |
182,446 |
182,525 |
||||
|
|
Net fair value |
79 |
- |
182,446 |
182,525 |
||||
|
|
|
|
|
|
|
||||
|
|
|
|
|
As at |
As at |
||||
|
|
|
|
|
30 September 2025 |
30 September 2024 |
||||
|
|
Level 3 Financial assets at realisable value through profit or loss |
|
|
£'000 |
£'000 |
||||
|
|
Opening fair value |
|
|
182,446 |
198,450 |
||||
|
|
Purchases including calls (at cost) |
|
|
9,368 |
11,210 |
||||
|
|
Disposals and return of capital |
|
|
(46,670) |
(9,281) |
||||
|
|
Total gains or losses included in losses on investments in the Statement of Comprehensive Income: |
|
|
|
|
||||
|
|
- assets disposed of during the period |
|
|
9,990 |
1,233 |
||||
|
|
- assets held at the end of the period |
|
|
(53,736) |
(19,166) |
||||
|
|
Closing balance |
|
|
101,398 |
182,446 |
||||
|
|
|
|
|
|
|
||||
|
|
The Company's holdings in unlisted investments are classified as Level 3. In respect of prior periods, unquoted investments, including those in Limited Partnerships ("LPs") have generally been valued by the Directors at fair value using International Private Equity and Venture Capital Valuation Guidelines. |
||||||||
|
|
The Board has determined that the going concern basis of preparation of the financial statements for the six months ended 30 September 2025 is no longer appropriate given that the likely outcome of the current sales process will ultimately lead to the proposed liquidation of the Company following further expected sales and returns of capital. Investments held at 30 September 2025 are shown at realisable value. |
||||||||
|
|
Events subsequent to the balance sheet date have been taken into account in preparing these financial statements, in particular adjustments to the valuation of the Company's investments and provisions for the completion of the Secondary Sales Process using best estimates following the bidding process undertaken by the Company's appointed agent. |
||||||||
|
|
As noted in the Chairman's Statement the Company signed binding sale and purchase agreements for a number of fund interests with Patria Investments Group on 29 September 2025. These sales are conditional, amongst other things, on General Partner consent to the transfers. Consequently these investments are shown on the balance sheet at 30 September 2025 as "Investments at realisable value through profit and loss" until such time as the conditionality is met. |
||||||||
|
13. |
Related party disclosures |
|
|
|
Transactions with the Manager. The investment management fee is levied by AFML at the following tiered levels, payable monthly in arrears: |
|
|
|
- 0.50% per annum in respect of the first £300 million of the net asset value (with debt at fair value in prior year); and |
|
|
|
- 0.45% per annum in respect of the balance of the net asset value (with debt at fair value in prior year). |
|
|
|
The Company also receives rebates with regards to underlying investments in other funds managed by the Group (where an investment management fee is charged by the Group on that fund) in the normal course of business to ensure that no double counting occurs. Any investments made in funds managed by the Group which themselves invest directly into alternative investments including, but not limited to, infrastructure and property are charged at the Group's lowest institutional fee rate. To avoid double charging, such investments are excluded from the overall management fee calculation. |
|
|
|
The table below details all investments held at 30 September 2025 that were managed by the Group. |
|
|
|
|
|
|
|
|
30 September 2025 |
|
|
|
£'000 |
|
|
SL Capital Infrastructure IIA |
17,947 |
|
|
Andean Social Infrastructure Fund IA |
13,249 |
|
|
Aberdeen Property Secondaries Partners IIB |
3,515 |
|
|
Aberdeen Global Infrastructure Partners II (AUD)A |
1,919 |
|
|
Aberdeen European Residential Opportunities FundC |
- |
|
|
|
36,630 |
|
|
A The value of this holding is removed from the management fee calculation to ensure that no double counting occurs. |
|
|
|
B An amount equivalent to the management fee received by the Manager on the underlying is offset against the management fee payable by the Company to ensure that no double counting occurs. |
|
|
|
C Value of holding written down to nil on 31 January 2025. |
|
|
14. |
Segmental information |
|
|
|
The Directors are of the opinion that the Company is engaged in a single segment of business being investment business. |
|
|
15. |
Subsequent events |
|
|
Subsequent to the balance sheet date and up to the date of this report, the Company has completed, or expects to complete, the disposal of substantially all of the investment portfolio. All necessary adjustments have been made to these financial statements, and no further material adjustments are anticipated. |
|
16. |
Half-Yearly Report |
|
|
The financial information in this Half-Yearly Report does not comprise statutory accounts within the meaning of sections 434 - 436 of the Companies Act 2006. The financial information for the year ended 30 September 2024 has been extracted from published accounts that have been delivered to the Registrar of Companies and on which the report of the auditors was unqualified and contained no statement under section 498 (2), (3) or (4) of the Companies Act 2006. The interim accounts have been prepared using the same accounting policies as the preceding annual accounts. |
|
17. |
This Half-Yearly Report was approved by the Board and authorised for issue on 19 December 2025. |
END